IRCT20170417033489N8 IRCT 2021-07-05 Mashhad University of Medical Sciences The effect of gabapentin supplementation in ureteral stone patients Evaluation of the increasing effect of gabapentin supplementation on standard (anticholinergic) treatment in controlling stimulus symptoms after double J stent placement in ureteral stone patients 2021-06-22 anticipated 76 Complete https://irct.ir/trial/56134 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: After the visit of each patient with inclusion criteria, an envelope is taken in order and according to the code written in it (for example a / b) the patient is placed in one of two groups, Blinding description: After the visit of each patient with inclusion criteria, an envelope is taken in order and according to the code written in it (for example a / b) the patient is placed in one of two groups. 3 ureteral stone disease. Intervention 1: Intervention group: Treated with anticholinergics and gabapentin 100 mg orally once daily. Solifenacin 5 mg orally is used as an anticholinergic drug. After 2 weeks from the start of treatment, the results of improving the irritating symptoms are re-evaluated using the Persian version of the ureteral stent symptom questionnaire (USSQ). In order to record other information such as patients' personal information, medical records and possible drug side effects during the study (dry mouth, hot flashes, temporary loss of balance, headache, drowsiness, body aches, etc.) from a simple design checklist Will be used by researchers. Intervention 2: Control group: Second, they are treated with anticholinergics and placebo with the same prescription as the intervention group. and 5 mg oral sulfinacin is used as an anticholinergic drug. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no more information